롱

Medlab Ascending Channel

128
(ASX:MDC) Medlab Clinical Ltd is an Australian, publicly listed biotechnology company that is finding new ways to address the biggest challenges of our time including the growing burden of cancer, suboptimal pain management as well as enhancing drug delivery with nanotechnology.

Bullish Outlook:
- Ascending Channel
- Internal Uptrend
- Bounce off RSI 50.00
- MACD crossing Bullish
- Testing Daily Resistance
- Positive Product Announcement

Looking to see if price will break upper band of Ascending Channel and test former Resistance levels which align with TB Fib Extension Targets (1.), or will price consolidate for a short time before it breaks Daily Resistance after retesting Internal Uptrend Trendline (2.)

Bearish Outlook:
If Internal Uptrend Fails then a return to Daily Resistance and Lower band of Ascending Channel is likely, If it is to fail then there are 2 levels of former Support to watch (3.)

"DISCLAIMER: NO ADVICE. The information presented here is general in nature and is for education purposes only. Nothing should be considered to be advice. You should consult with an appropriate professional for specific advice tailored to your situation."

면책사항

해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.